Thejus T Jayakrishnan

16PUBLICATIONS
50CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer diagnosisCancer geneticsAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Nov 03, 2026
A Phase 1 Trial of Low-dose Gemcitabine Combined with ATR Inhibitor Elimusertib for Advanced Solid Tumors.

|Oct 11, 2025
Causes of Death Among Individuals With Lynch Syndrome in the Immunotherapy Era.

Asaf Maoz, Leah Biller, Marios Giannakis

|Aug 05, 2024
Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers.

Thejus Jayakrishnan, Yasmine Baca, Joanne Xiu

|Jul 17, 2024
Multi-omics machine learning to study host-microbiome interactions in early-onset colorectal cancer.

Thejus T Jayakrishnan, Naseer Sangwan, Shimoli V Barot

|Mar 28, 2024
Gut Microbiome-Colorectal Cancer Relationship.

Devvrat Yadav, Chiranjeevi Sainatham, Evgenii Filippov

|Jan 09, 2023
Comparison of characteristics and outcomes of young-onset versus average onset pancreatico-biliary adenocarcinoma.

Thejus Jayakrishnan, Kanika G Nair, Suneel D Kamath

Pageof 3

Frequent Collaborators

3 joint publications

Suneel D Kamath

2 joint publications

Douglas Rubinson

2 joint publications

Leah H Biller

1 joint publications

Mizba Baksh